Quest Diagnostics (DGX) Accumulated Expenses (2010 - 2025)

Quest Diagnostics has reported Accumulated Expenses for 14 years, with the latest figure at $338.0 million in Q4 2025.

• Quarterly Accumulated Expenses rose 10.46% year-over-year to $338.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $338.0 million (up 10.46% YoY) and the FY2025 annual result came in at $338.0 million, up 10.46% from the prior year.
• Accumulated Expenses rose to $338.0 million in Q4 2025 per DGX's latest filing, from $306.0 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $460.0 million in Q4 2021 and troughed at $287.0 million in Q4 2023.
• A 5-year average of $356.6 million and a median of $338.0 million in 2025 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2021 and 2023: Accumulated Expenses gained 29.21% in 2021, then declined 26.79% in 2023.
• Over 5 years, Accumulated Expenses stood at $460.0 million in 2021, then decreased by 14.78% to $392.0 million in 2022, then declined by 26.79% to $287.0 million in 2023, then rose by 6.62% to $306.0 million in 2024, then rose by 10.46% to $338.0 million in 2025.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $338.0 million, $306.0 million, and $287.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.